Literature DB >> 1282484

How can peptide vaccines work?

D J Rowlands1.   

Abstract

Peptide antigens frequently induce antibodies which recognise the denatured form of a protein from which their sequences are derived. However, the ability to induce antibodies which crossreact with the native, fully folded form of the protein is less commonly observed. Although there is a growing number of examples in which this is the case, the ability to predict peptides having this property is extremely limited. Given the large surface areas involved in antibody/antigen interaction it is surprising that peptides could ever induce antibodies which would recognise the native protein well enough to have biological activity, such as the neutralization of infectivity. A mechanism is proposed to explain such observations which is compatible with many of the properties of antipeptide antibodies.

Mesh:

Substances:

Year:  1992        PMID: 1282484     DOI: 10.1111/j.1574-6968.1992.tb14080.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

Review 1.  Optimal delivery of vaccines: clinical pharmacokinetic considerations.

Authors:  S Gizurarson
Journal:  Clin Pharmacokinet       Date:  1996-01       Impact factor: 6.447

2.  Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope.

Authors:  W Xu; A D Ellington
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

3.  Structure-based vaccines provide protection in a mouse model of ehrlichiosis.

Authors:  Sunil Thomas; Nagaraja R Thirumalapura; Patricia A Crocquet-Valdes; Bruce A Luxon; David H Walker
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.